- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Insulin Glargine
Total 2809 results
-
SanofiCompletedDiabetes MellitusSweden, Finland, Netherlands, United Kingdom
-
Hoffmann-La RocheTerminatedDiabetes Mellitus Type 2China, Hong Kong, Korea, Republic of, Philippines, Taiwan, Malaysia, Thailand
-
Emory UniversityCompletedHyperglycemiaUnited States
-
SanofiPopulation Health Research InstituteCompletedDiabetes Mellitus, Non-Insulin-DependentUnited States, France, Brazil, Poland, Romania, Germany, Italy, Netherlands, Spain, Sweden, Switzerland, Turkey, India, Philippines, Russian Federation, Slovakia, Mexico, Argentina, Croatia, Austria, Denmark, Finland, Hungary, Lithuania, Norw... and more
-
Emory UniversityMerck Sharp & Dohme LLCCompletedHyperglycemia | Type 2 Diabetes Mellitus | HospitalizationUnited States
-
HealthPartners InstituteTerminated
-
Profil Institut für Stoffwechselforschung GmbHSanofiCompleted
-
SanofiCompleted
-
ikfe-CRO GmbHIKFE Institute for Clinical Research and DevelopmentCompletedType 2 Diabetic Patients | Insufficient Metabolic Control | OAD TreatmentGermany
-
Fundación Pública Andaluza para la Investigación...CompletedType 1 Diabetes MellitusSpain
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Germany
-
Sansum Diabetes Research InstituteNovo Nordisk A/SCompletedDiabetes Mellitus, Type 1United States
-
SanofiCompleted
-
Eli Lilly and CompanyRecruitingCardiovascular Diseases | Obesity | Overweight | Type 2 Diabetes | Chronic Kidney Disease | Overweight or ObesityUnited States, Italy, Spain, Korea, Republic of, India, Turkey, Austria, Puerto Rico, Mexico, Romania, Brazil, Germany, Argentina, Czechia, Greece, Slovakia
-
Eli Lilly and CompanyCompletedType 2 Diabetes MellitusIndia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
AstraZenecaEli Lilly and CompanyCompletedType 2 Diabetes MellitusSweden, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Estonia, Romania, Finland, Netherlands, Argentina, Belgium, Germany, Portugal, United Kingdom, Greece, France, Puerto Rico
-
Emory UniversityNovo Nordisk A/SCompleted
-
Northwestern UniversityTerminatedInsulin Resistance, Diabetes | Hyperglycemia Steroid-inducedUnited States
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1United Kingdom, United States, Australia, Canada, Poland, Denmark, Spain, Croatia, Sweden, Greece, Belgium, France, New Zealand, South Africa, Israel, Brazil, Ireland, Netherlands, Lithuania, Slovakia
-
Eli Lilly and CompanyCompleted
-
SanofiCompletedDiabetes Mellitus, Type 2France, Germany, Netherlands, Spain, Sweden, Switzerland, United Kingdom, Finland, Italy, Austria
-
University of Alabama at BirminghamRecruitingDiabetes Mellitus, Type 2 | Preterm Birth | Pregnancy, High Risk | Diabetes, GestationalUnited States
-
SanofiCompletedType 2 Diabetes MellitusUkraine
-
Jiangsu HengRui Medicine Co., Ltd.Recruiting
-
University of Alabama at BirminghamNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)RecruitingType 2 DiabetesUnited States
-
Hospital Central "Dr. Ignacio Morones Prieto"CompletedAngiogenesis | Varicose Ulcer | Insulin | Wound Healing | Chronic Venous DiseaseMexico
-
Eli Lilly and CompanyCompletedDiabetes MellitusSouth Africa
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Germany
-
GeropharmCompletedDiabetes Mellitus, Type 2Russian Federation
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesChina
-
Nanjing First Hospital, Nanjing Medical UniversityUnknown
-
University of the Highlands and IslandsCompletedEndothelial DysfunctionUnited Kingdom
-
Eli Lilly and CompanyBoehringer IngelheimCompletedDiabetes Mellitus, Type 2United States, Puerto Rico, Mexico, Korea, Republic of, Germany, Poland, Taiwan, Spain, Greece, France, Czech Republic, Hungary
-
SanofiCompletedDiabetes Mellitus, Type 2Japan, Russian Federation, China, India, Pakistan, Philippines
-
The Coca-Cola CompanyCompletedObesity | OverweightSpain
-
SanofiCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1Austria, Switzerland, United Kingdom, Germany, Ireland
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesItaly, Poland, Denmark, France, Netherlands, Austria, Spain, Finland, Argentina, India, Russian Federation, United Kingdom, Slovakia, Brazil, Norway, Former Serbia and Montenegro, South Africa, Philippines
-
Eli Lilly and CompanyCompletedA Comparison Study of Basal Bolus Therapies Together With Lispro Insulin in Type 2 Diabetes PatientsDiabetes Mellitus, Type 2Romania, Italy, Belgium, Poland, Greece, Germany, United Kingdom, Turkey, Czech Republic, Slovakia
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 1Japan, United States, Russian Federation, France, Mexico, Austria, Germany, Italy, Poland
-
SanofiCompletedType 2 Diabetes MellitusUnited States, Argentina, Brazil, Canada, Chile, Colombia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, India, Israel, Italy, Malaysia, Mexico, Netherlands, Poland, Puerto Rico, Romania, Russian Federation, South Africa, Swed... and more
-
SanofiCompletedDiabetes Mellitus, Type 2Korea, Republic of
-
Chungbuk National University HospitalActive, not recruitingType 2 Diabetes Mellitus | Glucose, High BloodKorea, Republic of
-
Eli Lilly and CompanyCompletedDiabetes Mellitus, Type 2Turkey, Argentina, Korea, Republic of, Brazil, China, Egypt, India, Spain
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesDenmark
-
University of GuadalajaraCompletedType 2 Diabetes MellitusMexico
-
Emory UniversityAmerican Diabetes AssociationCompleted
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | Diabetes | Diabetes Mellitus, Type 1China
-
Novo Nordisk A/SCompletedDiabetes Mellitus, Type 2 | DiabetesSaudi Arabia, Egypt